Aytu Biopharma (AYTU) Research & Development (2014 - 2025)
Aytu Biopharma (AYTU) reported Research & Development of $216000.0 for Q2 2025, down 79.27% year-over-year from $1.0 million in Q2 2024, and up 33.33% quarter-over-quarter from $162000.0 in Q1 2025.
Aytu Biopharma (AYTU) Research & Development (2014 - 2025) Analysis & Trends
Aytu Biopharma (AYTU) has 12 years of Research & Development data on file, last reported at $216000.0 in Q2 2025.
- Research & Development for Q2 2025 came in at $216000.0, down 79.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $216000.0 (down 89.96% YoY), and the FY2025 annual result was $1.3 million, down 52.11% from the prior year.
- Research & Development climbed to $216000.0 in Q2 2025 per AYTU's latest filing, from $162000.0 in the prior quarter.
- Over five years, Research & Development peaked at $4.8 million in Q2 2021 and troughed at $162000.0 in Q1 2025.
- A 5-year average of $1.5 million and a median of $856000.0 in 2023 frame the typical range for Research & Development.
- The sharpest annual moves came in 2021 and 2023: Research & Development soared 1464.69% in 2021, then plunged 85.71% in 2023.
- A 5-year view of Research & Development shows it stood at $4.5 million in 2021, then tumbled by 61.79% to $1.7 million in 2022, then slumped by 69.53% to $521000.0 in 2023, then gained by 0.19% to $522000.0 in 2024, then tumbled by 58.62% to $216000.0 in 2025.
- Business Quant data shows AYTU's Research & Development at $216000.0 in Q2 2025, $162000.0 in Q1 2025, and $522000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 222.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 180.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 138.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 934,363.43 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 296.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 97.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 103.35 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 39.38 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 46.94 Mn |
| 10 | Aytu Biopharma | 24.18 Mn | -2.54 Mn | 7.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 216,000.00 |
| Mar 31, 2025 | 162,000.00 |
| Dec 31, 2024 | 522,000.00 |
| Sep 30, 2024 | 426,000.00 |
| Jun 30, 2024 | 1.04 Mn |
| Mar 31, 2024 | 611,000.00 |
| Dec 31, 2023 | 521,000.00 |
| Sep 30, 2023 | 595,000.00 |
| Jun 30, 2023 | 465,000.00 |
| Mar 31, 2023 | 856,000.00 |
| Dec 31, 2022 | 1.71 Mn |
| Sep 30, 2022 | 1.06 Mn |
| Jun 30, 2022 | 3.25 Mn |
| Mar 31, 2022 | 3.28 Mn |
| Dec 31, 2021 | 4.48 Mn |
| Sep 30, 2021 | 1.65 Mn |
| Jun 30, 2021 | 4.76 Mn |
| Dec 31, 2020 | 286,000.00 |
| Sep 30, 2020 | 183,000.00 |
| Jun 30, 2020 | 1.50 Mn |